Safety shoes Base i-Cyber Fluo Top B1213A S1P ESD SRC

The Base i-Cyber Fluo Top B1213A S1P ESD SRC safety shoes are one of the most innovative models in the new i4 Hi-tech 4.0 collection, aimed at workers who maintain a fixed, standing position for prolonged periods during the day.

Even in the hottest season, the boot is highly appreciated by those who need a shoe that protects them and keeps their feet supported without stress! The i-Cyber Fluo Top B1213A S1P ESD is electrically dissipative, constantly discharging the electrical charges accumulated by the human body during use to the ground, preventing so-called electric shocks, which are responsible for serious accidents that are difficult to manage.

In addition, the i-Cyber Fluo Top B1213A footwear is made as follows:

• Boot-like upper made of technical fabric and water-repellent microfibre, resistant to wear and tear 

• An oversized padded collar that reduces pressure on the heel area to improve bending

• Toe cap coated with ultra abrasion-resistant material

• Smelltop 3D fabric lining with anti-bacterial treatment that eliminates odour and prevents the growth of bacteria and fungi

• NON-metallic toe cap resistant up to 200J with 35% less thickness than other types; a protective band adhered to the toe cap prevents pressure and pain to the toes.

• Fresh'n Flex non-metallic puncture-resistant liner with ballistic fabric inserts 0 mm perforation.

• Flexible, lightweight AirTech+ Tpu-Skin outsole designed to reduce the thickness of the tread and improve the flexibility of the foot during movement

• Omnia Weareco Dry'n Air ESD insole with air circulation that ensures the right foot temperature all day long

• Reinforced rear heel to protect the foot from accidental impact

The Base i-Cyber Fluo Top shoes are completely Metal-Free, ideal for working in environments with the presence of Metal Detectors; they are made in sizes 35 to 48 in different 10.5 and 11.5 Mondopoint fits. The wide fit is suitable for orthopaedic insoles for those who suffer from foot pathologies, according to DGUV 112-191.